Life Science Leader recognizes CMC Biologics for quality, reliability for third consecutive year

Mar 19 2015

CMC Biologics, Inc., a leading global contract manufacturing organization known for technical excellence and customer satisfaction in biopharmaceutical development and commercial manufacture of protein-based therapeutics, was recognized for the third consecutive year for quality and reliability by Life Science Leader at an awards ceremony at DCAT Week '15 in New York.

"The CMC Biologics' team is honored to receive this prestigious award as recognition from our customers and the industry as a whole," said Gustavo Mahler, PhD, Global Chief Operations Officer. "Our customers count on us to deliver comprehensive process development and manufacturing solutions essential for their clinical and commercial success; and this award underscores our proven track-record in technical excellence and customer satisfaction across every aspect of our business."

Bringing new pharmaceutical products to market is time consuming and costly, thereby having reliable and effective contract organizations to work with helps streamline that process. The Life Science Leader CMO Leadership awards are designed to honor top performers based on survey responses from thousands of industry executives, conducted by Nice Insight, and to better serve biopharmaceutical executives in their CMO selection process. This data will help companies focus on potential CMO partners who can manage their projects and are considered most reputable in the industry.